Patents by Inventor Roger Ferrini

Roger Ferrini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor
    Publication number: 20230348589
    Abstract: The present invention relates to novel antibodies and fragments thereof that binds cannabinoid 1 (CB1) receptor. The antibodies and fragments thereof as disclosed herein include humanized antibodies that bind CB1 receptor. The invention also includes uses of the antibodies for treating a disease or disorder responsive to antagonism or agonism of the CB1 receptor.
    Type: Application
    Filed: January 27, 2023
    Publication date: November 2, 2023
    Inventors: Anke Kretz-Rommel, Lei Shi, Roger Ferrini, Teddy Yang, Fei Xu, Brian Campion
  • ANTIBODIES THAT BIND HUMAN CANNABINOID 1 (CB1) RECEPTOR
    Publication number: 20230159634
    Abstract: The present invention relates to novel antibodies and fragments thereof that binds cannabinoid 1 (CB1) receptor. The antibodies and fragments thereof as disclosed herein include humanized antibodies that bind CB1 receptor. The invention also includes uses of the antibodies for treating a disease or disorder responsive to antagonism or agonism of the CB1 receptor.
    Type: Application
    Filed: July 29, 2022
    Publication date: May 25, 2023
    Inventors: Anke Kretz-Rommel, Roger Ferrini
  • Treatment of disease responsive to modulation of cannabanoid 1(CB1) receptor signaling
    Patent number: 11566069
    Abstract: The present invention relates to novel antibodies and fragments thereof that binds cannabinoid 1 (CB1) receptor. The antibodies and fragments thereof as disclosed herein include humanized antibodies that bind CB1 receptor. The invention also includes uses of the antibodies for treating a disease or disorder responsive to antagonism or agonism of the CB1 receptor.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: January 31, 2023
    Assignee: Bird Rock Bio, Inc.
    Inventors: Anke Kretz-Rommel, Lei Shi, Roger Ferrini, Teddy Yang, Fei Xu, Brian Campion
  • Antibodies that bind human cannabinoid 1 (CB1) receptor
    Patent number: 11421026
    Abstract: The present invention relates to novel antibodies and fragments thereof that binds cannabinoid 1 (CB1) receptor. The antibodies and fragments thereof as disclosed herein include humanized antibodies that bind CB1 receptor. The invention also includes uses of the antibodies for treating a disease or disorder responsive to antagonism or agonism of the CB1 receptor.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: August 23, 2022
    Assignee: Bird Rock Bio, Inc.
    Inventors: Anke Kretz-Rommel, Roger Ferrini
  • Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor
    Publication number: 20190315856
    Abstract: The present invention relates to novel antibodies and fragments thereof that binds cannabinoid 1 (CB1) receptor. The antibodies and fragments thereof as disclosed herein include humanized antibodies that bind CB1 receptor. The invention also includes uses of the antibodies for treating a disease or disorder responsive to antagonism or agonism of the CB1 receptor.
    Type: Application
    Filed: January 25, 2019
    Publication date: October 17, 2019
    Inventors: Anke Kretz-Rommel, Lei Shi, Roger Ferrini, Teddy Yang, Fei Xu, Brian Campion
  • Antibodies that bind human cannabinoid 1 (CB1) receptor
    Patent number: 10308712
    Abstract: The present invention relates to novel antibodies and fragments thereof that binds cannabinoid 1 (CB1) receptor. The antibodies and fragments thereof as disclosed herein include humanized antibodies that bind CB1 receptor. The invention also includes uses of the antibodies for treating a disease or disorder responsive to antagonism or agonism of the CB1 receptor.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: June 4, 2019
    Assignee: BIRD ROCK BIO, INC.
    Inventors: Anke Kretz-Rommel, Lei Shi, Roger Ferrini, Teddy Yang, Fei Xu, Brian Campion
  • ANTIBODIES THAT BIND HUMAN CANNABINOID 1 (CB1) RECEPTOR
    Publication number: 20180282406
    Abstract: The present invention relates to novel antibodies and fragments thereof that binds cannabinoid 1 (CB1) receptor. The antibodies and fragments thereof as disclosed herein include humanized antibodies that bind CB1 receptor. The invention also includes uses of the antibodies for treating a disease or disorder responsive to antagonism or agonism of the CB1 receptor.
    Type: Application
    Filed: September 27, 2016
    Publication date: October 4, 2018
    Inventors: Anke Kretz-Rommel, Roger Ferrini
  • Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor
    Publication number: 20170210797
    Abstract: The present invention relates to novel antibodies and fragments thereof that binds cannabinoid 1 (CB1) receptor. The antibodies and fragments thereof as disclosed herein include humanized antibodies that bind CB1 receptor. The invention also includes uses of the antibodies for treating a disease or disorder responsive to antagonism or agonism of the CB1 receptor.
    Type: Application
    Filed: March 27, 2015
    Publication date: July 27, 2017
    Inventors: Anke Kretz-Rommel, Lei Shi, Roger Ferrini, Teddy Yang, Fei Xu, Brian Campion
  • Polypeptides that Bind TRAIL-R1 and TRAIL-R2
    Publication number: 20120021995
    Abstract: Agonists for TRAIL death receptors including polypeptides that bind to TRAIL death receptor TRAIL-R1 (DR4) and/or TRAIL-R2 (DR5) and optionally having a multimerizing, e.g. trimerizing domain. Agonists are described that do not bind to TRAIL decoy receptors. The multimerizing domain may be derived from human tetranectin. The agonists can induce apoptosis in pathogenic cells expressing a TRAIL death receptor. Pharmaceutical compositions are described for treating diseases associated with cells expressing DR4 and DR5, such as tumor cells. Methods for selecting polypeptides and preparing multimeric complexes.
    Type: Application
    Filed: July 26, 2011
    Publication date: January 26, 2012
    Applicant: ANAPHORE, INC.
    Inventors: Katherine Bowdish, Anke Kretz-Rommel, Mark Renshaw, Bing Lin, Jean de Silva Correia, Roger Ferrini, Elise Chen